Showing results (621-630 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|June 27, 2019
Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire StudySandra L Kane-Gill, Marlies Ostermann, Jing Shi, et al.Drug Safety|July 1, 2017
Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective SurveillanceRolina D van Gaalen, Michal Abrahamowicz, David L BuckeridgeDrug Safety|April 10, 2021
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in JapanRika Wakao, Ingrid M Lönnstedt, Yasunori Aoki, et al.Drug Safety|August 1, 2012
Early investigation of QTc liability: the role of multiple ascending dose (MAD) studyRashmi R Shah, Joel MorganrothDrug Safety|September 13, 2012
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysisHoda Moteshafi, Simon Zhornitsky, Sarah Brunelle, et al.Drug Safety|May 2, 2023
Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup RiskOlivia Mahaux, Greg Powell, François Haguinet, et al.Drug Safety|May 2, 2023
Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover StudyKasper Bonnesen, Lars Pedersen, Vera Ehrenstein, et al.Drug Safety|August 15, 1998
Adverse haematological effects of ticlopidine. Prevention, recognition and managementB B Love, J Biller, M GentDrug Safety|August 15, 1998
A risk-benefit assessment of alendronate in the treatment of involutional osteoporosisJ P DevogelaerPageof 308